Article info
PDFArchimedes
Should levetiracetam rather than phenobarbitone be the first-line treatment for neonatal seizures?
- Correspondence to Dr Kathleen M Gorman, Department of Neurology and Clinical Neurophysiology, Children's Health Ireland at Temple Street, Dublin D01 YC67, Ireland; kathleen.gorman{at}cuh.ie
Citation
Should levetiracetam rather than phenobarbitone be the first-line treatment for neonatal seizures?
Publication history
- Received July 22, 2020
- Revised September 26, 2020
- Accepted September 27, 2020
- First published October 23, 2020.
Online issue publication
February 19, 2021
Article Versions
- Previous version (23 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.